AONC (AON) Cumulative Company Assets

Official company branding of American Oncology Network (AONC)

This price chart illustrates the dynamics of American Oncology Network (AONC) total assets, which currently stand at 292.98. American Oncology Network (AONC) integrates regional specialists to provide high-tech patient care close to their homes. Business growth relies on scaling its B2B platform to expand market presence, while a steady influx of clients ensures sufficient working capital for network development.

American Oncology Network (AONC) Aggregate Company Assets: for the period 02/21/2024 - 08/04/2024
Core merchandise of American Oncology Network

Total assets determine the overall scale of the company's resources, where the growth of property and resources, calculated inversely through return on assets (ROA), demonstrates the actual capacity of the business. This metric allows an investor to assess the fundamental power of American Oncology Network (AONC), reflecting the expansion of the high-tech oncology clinic network and the capitalization of patient trust through the broadening of the medical care material base.

Key competitors

Cumulative Company Assets beigene.com|HALO (Halozyme) - Company Total Assets|Cumulative Company Assets Revolution Medicines Inc (RVMD)|Company Total Assets AAPG|Company Total Assets CG Oncology Therapeutics (CGON)|Aggregate Company Assets UroGen Pharma Ltd. URGN|BCAX: Total Business Assets|Personalis - Company Total Assets|Erasca Inc (ERAS) - Cumulative Company Assets|DCTH: Company Total Assets|Company Assets Y-mAbs Corp (YMAB)|Aggregate Company Assets Aura Biosciences, Inc.|CADL: Aggregate Asset Value|Cumulative Company Assets ARAY (Accuray)|SLS (sellaslifesciences.com) - Aggregate Asset Value|Company Total Assets ACTU (Actuate Therapeutics, Inc)|CTOR - Cumulative Company Assets|HURA: Cumulative Company Assets|TARA - Company Total Assets|Fate Therapeutics (FATE) - Aggregate Company Assets|Aadi Bioscience - Aggregate Asset Value|TCRX (TScan Therapeutics Inc) - Company Total Assets|Company Assets Champions Oncology Corp CSBR|Company Total Assets XBIT|Company Total Assets cel-sci.com (CVM)|Aggregate Company Assets OS Therapies OSTX|RADX - Cumulative Company Assets|Artiva - Company Total Assets|Company Assets Adlai Nortye Ltd.|Veru Inc. (VERU) - Aggregate Company Assets|tempesttx.com - Aggregate Asset Value|XLO (Xilio Therapeutics Inc) - Company Total Assets|Enochian BioSciences (RENB) - Company Total Asset Base|Company Total Assets MURA|Cumulative Company Assets kairospharma.com KAPA|Company Total Assets OKUR (OnKure Therapeutics)|Company Total Assets CytoMed Therapeutics Ltd GDTC|CRIS - Aggregate Company Assets|APLM (Apollomics, Inc.) - Total Business Assets|THAR (Tharimmune Corp) - Cumulative Company Assets|Advanced Biomed - Aggregate Asset Value|Aggregate Company Assets Genprex, Inc.|Company Assets Calidi Bio CLDI|Aggregate Company Assets Sunshine Biopharma, Inc. (SBFM)|xeneticbio.com - Total Business Assets|Company Total Assets SLRX (Salarius)|PPBT - Cumulative Company Assets|BGNE - Aggregate Company Assets|Company Assets checkpointtx.com|Elevation Oncology (ELEV) - Aggregate Company Assets|ICAD (iCAD) - Aggregate Company Assets|Aggregate Company Assets Ikena Oncology Inc.|Company Assets Notable Labs Corp NTBL|Company Total Assets VIRX|morphosys.com (MOR) - Company Balance Sheet Assets|NAYA Biosciences Inc. - Cumulative Company Assets|Ascentage Pharma Group International (AAPGV) - Company Assets